Journal
CELL
Volume 155, Issue 1, Pages 27-38Publisher
CELL PRESS
DOI: 10.1016/j.cell.2013.09.006
Keywords
-
Categories
Funding
- NHGRI NIH HHS [U54 HG003079] Funding Source: Medline
Ask authors/readers for more resources
Genomics is a relatively new scientific discipline, having DNA sequencing as its core technology. As technology has improved the cost and scale of genome characterization over sequencing's 40-year history, the scope of inquiry has commensurately broadened. Massively parallel sequencing has proven revolutionary, shifting the paradigm of genomics to address biological questions at a genome-wide scale. Sequencing now empowers clinical diagnostics and other aspects of medical care, including disease risk, therapeutic identification, and prenatal testing. This Review explores the current state of genomics in the massively parallel sequencing era.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available